Page last updated: 2024-09-03

gefitinib and gtp 14564

gefitinib has been researched along with gtp 14564 in 1 studies

Compound Research Comparison

Studies
(gefitinib)
Trials
(gefitinib)
Recent Studies (post-2010)
(gefitinib)
Studies
(gtp 14564)
Trials
(gtp 14564)
Recent Studies (post-2010) (gtp 14564)
5,2315662,919704

Protein Interaction Comparison

ProteinTaxonomygefitinib (IC50)gtp 14564 (IC50)
Macrophage colony-stimulating factor 1 receptorHomo sapiens (human)0.3
Platelet-derived growth factor receptor betaHomo sapiens (human)1
Mast/stem cell growth factor receptor KitHomo sapiens (human)0.3
Receptor-type tyrosine-protein kinase FLT3Homo sapiens (human)0.3

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M1

Other Studies

1 other study(ies) available for gefitinib and gtp 14564

ArticleYear
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

    Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007